Skip to content

Valneva

  • About Us
    About Us Advancing vaccines for better lives Learn More
    • Our Strategy
    • Our Responsibility
    • Our Team
  • Products
    Products Focusing on vaccines for infectious diseases with major unmet needs. Learn More
    • Japanese Encephalitis Vaccine
    • Cholera Vaccine
    • Marketing and Distribution
    • Manufacturing and Services
  • R&D
    R&D Dedicated to innovation in vaccine research and development. Learn More
    • Pipeline
    • Lyme Disease – VLA15
    • Chikungunya – VLA1553
    • COVID-19 – VLA2001
    • Zika – VLA1601
    • Clostridium Difficile – VLA84
    • Scientific Publications
  • Investors
    Investors Unlocking value for our shareholders Learn More
    • Events and Presentations
      • Calendar
      • Corporate Presentations
    • Financial Reports
    • Videos and Webcasts
    • Stock Information
      • Stock Price
      • Analysts
      • Shareholder Structure
      • Vienna Stock Exchange Delisting
    • Corporate Governance
      • Corporate Compliance & Ethics
    • Regulated Information
    • Extraordinary General Meeting 2020
    • General Meeting Archive
      • Annual General Meeting 2020
    • Contact
  • Media
    Media Press releases, latest news and media resources Learn More
    • Press Releases
    • In The News
    • Media Kit
    • Media Contact
  • Careers
Contact
  • EN
  • FR
Search

Financial Reports

2020

  • First nine months results 2020
  • 2020 Half-Year Report
  • First quarter results 2020

2019

Corporate Social Responsibility Report Rapport RSE / Déclaration de performance extra-financière
  • 2019 Universal Registration Document
  • Valneva's 2019 Annual Business Report (electronic version)
  • 2019 Consolidated Financial Statements (IFRS) (unaudited)
  • First nine months results 2019
  • 2019 Half-Year Report
  • First quarter results 2019

2018

Corporate Social Responsibility Report Rapport RSE / Déclaration de performance extra-financière
  • 2018 Annual Business Report
  • 2018 Consolidated Financial Statements (IFRS) (audited)
  • 2018 Statutory Financial Statements (audited)
  • 2018 Consolidated Financial Statements (IFRS) (unaudited)
  • First nine months results 2018
  • Half-year report 2018
  • First quarter results 2018
  • Registration Document

2017

  • 2017 Annual Business Report
  • 2017 Consolidated Financial Statements (IFRS)
  • First nine months results / Third quarter report 2017
  • Second quarter results / Half-year report 2017
  • First quarter results 2017
  • Registration Document

2016

  • 2016 Annual Business Report
  • 2016 Consolidated Financial Statements (IFRS)
  • Third quarter results 2016
  • Second quarter results / Half-year report 2016
  • First quarter results 2016
  • Registration Document

2015

  • 2015 Annual Business Report
  • 2015 Annual Financial Report
  • Quarterly Split of Audited Consolidated Income Statement for the Year Ending December 31, 2015
  • Third quarter results 2015
  • Second quarter results / Half-year report 2015
  • First quarter results 2015
  • Registration Document

2014

  • 2014 Consolidated Financial Statements (IFRS)
  • 2014 Annual Business Report
  • 2014 Annual Financial Report (French GAAP)
  • Fourth quarter results & Annual Results 2014
  • Third quarter results 2014
  • Second quarter results / Half-year report 2014
  • First quarter results 2014
  • Registration Document

2013

  • 2013 IFRS Financial Statements Valneva SE
  • Third quarter results 2013
  • Third quarter results 2013 pro forma
  • Second quarter results / Half-year report 2013
  • Second quarter results / Half-year report 2013 pro forma
  • Registration Document

2012

  • 2012 IFRS Financial Statements Vivalis SA
  • Fourth quarter results 2012
  • Third quarter results 2012
  • Half-year report 2012
  • Second quarter results 2012
  • First quarter results 2012
  • Registration Document

2011

  • 2011 Annual Report Vivalis SA
  • Fourth quarter results 2011
  • Third quarter results 2011
  • Half-year report 2011
  • Second quarter results 2011

Valneva

  • About Us
  • Products
  • R&D
  • Investors
  • Media
  • Careers
Related Websites
  • Valneva Canada
  • Valneva UK
  • Valneva Austria
  • Valneva USA
  • Valneva Nordic
  • Valneva France
Contact
© 2021 Valneva SE. All rights reserved.
  • Legal Notice
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • 1907-00-VLA-002 | 11-JUL-2019
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.